govt.chinadaily.com.cn

News and Policies

TCM firm granted seal of approval during pandemic

Updated: Jul 9, 2020 By Yuan Shenggao chinadaily.com.cn Print
Share - WeChat
A warehouse worker checks boxes of Lianhuaqingwen capsules at a Shijiazhuang Yiling Pharmaceutical facility in Shijiazhuang, capital of Hebei province, on Jan 30, 2020. [Photo/Xinhua]

Innovative muscle

Behind the marked achievements is the company's strong research and development capacities.

"Sustainable innovation is the prime engine to drive Yiling's growth," said Wu Xiangjun, general manager of the company.

The company is home to a work station, where a group of academicians of the Chinese Academy of Sciences and the Chinese Academy of Engineering work toward major technological breakthroughs and training researchers.

They, together with other domestic experts, have formed an innovative development consulting committee and made a series of achievements in biopharmaceutical R&D.

The company has developed more than 10 patented drugs, all approved to go to market, news portal iFeng's financial channel reported.

Another group of 29 new drug varieties are under development, and more than 20 reserve varieties have been selected, forming a series of patented drugs at different R&D stages.

< 1 2 3 4

Copyright©2024 China Daily. All rights reserved.

京ICP备13028878号-6

京公网安 京公网安备 11010502032503号